THE VALUE OF A FUNCTIONAL EXCIPIENT ADDITIVE TO HUMAN INSULIN THERAPIES: FROM MANUFACTURE TO HUMAN CLINICAL TRIAL

THE VALUE OF A FUNCTIONAL EXCIPIENT ADDITIVE TO HUMAN INSULIN THERAPIES: FROM MANUFACTURE TO HUMAN CLINICAL TRIAL

Bibliographic Details
Main Author:	El Sanadi, Caroline Elizabeth
Language:	English
Published:	Case Western Reserve University School of Graduate Studies / OhioLINK 2015
Subjects:	Medicine Health Sciences Biomedical Research Biology Insulin Diabetes Type 1 Diabetes Type 2 Diabetes Liver Biotechnology Pharmaceutical Functional Excipient Additive
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=case1450286879

Similar Items

Anti-diabetic effects of excipients: possibility of formulation of an anti-diabetic dosage form using pharmaceutical excipients or their constituents, or food additives
by: Shireesh Apte
Published: (2010-03-01)

The Cost-effectiveness of Analogue Insulin Pens in Comparison with Human Insulin Pens for Controlling Type 1, Type 2, and Gestational Diabetes: A Systematic Review Article
by: Mohsen Pakdaman, et al.
Published: (2018-12-01)

The Expense of Insulin in Individuals with Insulin-Dependent Diabetes in Fars Province based on Prescribed Prescriptions including Insulin
by: Sanaz Amiri, et al.
Published: (2020-12-01)

Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis
by: Karla F. S. Melo, et al.
Published: (2019-01-01)

Clinical Experience of Insulin Detemir in Turkey: Efficacy and Safety Data From the PREDICTIVE™ Study
by: Gaye Akoz, et al.
Published: (2008-12-01)

Relationship between insulin treatment and diabetic retinopathy in patients with type 2 diabetes mellitus
by: Jiao Su, et al.
Published: (2019-03-01)

Degludec insulin: A novel basal insulin
by: Sanjay Kalra, et al.
Published: (2011-01-01)

Insulin injection site and time interval administration for the postprandial glucose control in patient with diabetes type 2: A randomized clinical trial
by: Agus Santosa, et al.
Published: (2018-01-01)

Reduction of glycemic variability with Degludec insulin in patients with unstable diabetes
by: Diana Cristina Henao-Carrillo, et al.
Published: (2018-06-01)

PHARMACEUTICAL EXCIPIENTS: GLOBAL REGULATORYISSUES
by: Harish Dureja, et al.
Published: (2013-10-01)

Effect of alcohol on insulin secretion and viability of human pancreatic islets
by: Nikolić Dragan, et al.
Published: (2017-01-01)

Insulin secretion, insulin sensitivity, and hepatic insulin extraction in first-degree relatives of type 2 diabetic patients
by: W.P. Pimenta, et al.
Published: (2003-03-01)

Study of phases of insulin secretion in pre-diabetes and newly diagnosed type 2 diabetes mellitus
by: Sabreena Mohtarin, et al.
Published: (2016-07-01)

Analysis of the effect of diabetes type 2 duration on beta cell secretory function and insulin resistance
by: Popović Ljiljana, et al.
Published: (2006-01-01)

Comparative analysis of glycemic control effectiveness and microvascular complications in patients with type 1 diabetes mellitus, treated with genetically engineered human insulin or human insulin analogues: A 10-year retrospective observational study
by: Marina V. Shestakova, et al.
Published: (2016-12-01)

Hypoglycemia incidence and awareness among insulin-treated patients with diabetes: the HAT study in Brazil
by: Rodrigo Nunes Lamounier, et al.
Published: (2018-11-01)

Pharmaceutical Excipients and Drug Metabolism: A Mini-Review
by: Rahul Patel, et al.
Published: (2020-11-01)

The relationship between insulin sensitivity and serum antithrombin 3 activity in patients with type 2 diabetes
by: Hong Wang, et al.
Published: (2021-06-01)

The use of metformin as an add-on therapy to insulin in the treatment of poorly controlled type 1 diabetes mellitus in adolescents
by: Katsiaryna Sikorskaya, BSN, RN, CSN, et al.
Published: (2021-03-01)

A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design
by: Kristensen Peter, et al.
Published: (2012-06-01)

Comparative Effects of Insulins: a Prospective Case for Tissue Specific Insulins
by: Tustan, Alisar Nicole
Published: (2018)

South Asian Consensus Guideline: Use of insulin in diabetes during Ramadan
by: Md Faruque Pathan, et al.
Published: (2012-01-01)

Living without insulin: the role of leptin signaling in the hypothalamus
by: Teppei eFujikawa, et al.
Published: (2015-03-01)

Blood glucose level and insulin resistance in patients with type 2 diabetic mellitus, diabetic retinopathy and obesity
by: N.V. Malachkova, et al.
Published: (2017-04-01)

Glycemic Effects of Once-a-Day Rapid-Acting Insulin Analogue Addition on a Basal Insulin Analogue in Korean Subjects with Poorly Controlled Type 2 Diabetes Mellitus
by: Eun Yeong Choe, et al.
Published: (2012-06-01)

Therapeutic potential for insulin on type 1 diabetes‐associated periodontitis: Analysis of experimental periodontitis in streptozotocin‐induced diabetic rats
by: Toru Nishikawa, et al.
Published: (2020-11-01)

Resveratrol Affects Insulin Signaling in Type 2 Diabetic Goto-Kakizaki Rats
by: Katarzyna Szkudelska, et al.
Published: (2021-02-01)

The Effect of Nanohydrogel Oral Insulin Therapy on Serum Glucose and Insulin Level in Patients with Type 2 Diabetes: A Pilot Study
by: Vali Ahmadi, Jalil Karnoosh-Yamchi, Akbar Aliasgharzadeh, Alireza Ostad-Rahimi, Zeinab Nikniaz, Roya Salehi, Majid Mobasseri
Published: (2016-09-01)

Concentrated insulins: the new basal insulins
by: Lamos EM, et al.
Published: (2016-03-01)

Short Course of Insulin Treatment versus Metformin in Newly Diagnosed Patients with Type 2 Diabetes
by: Marta Seghieri, et al.
Published: (2018-08-01)

Ultra‐Rapid Lispro results in accelerated insulin lispro absorption and faster early insulin action in comparison with Humalog® in Japanese patients with type 1 diabetes
by: Masanari Shiramoto, et al.
Published: (2020-05-01)

Insulin and heparin challenge tests are useful for choosing an optimal insulin regimen in a case of subcutaneous insulin resistance
by: Yuko Nakamura, et al.
Published: (2020-09-01)

Insulin usage and practices in children and adolescents with type 1 diabetes
by: Ashrita Donepudi, et al.
Published: (2021-01-01)

Effects of an actual insulin injection demonstration on insulin acceptance among patients with T2DM: a pragmatic randomized controlled trial
by: Choomai Atthayaporn, et al.
Published: (2021-06-01)

Association of serum ferritin with insulin resistance in offsprings of type 2 diabetics
by: Usama A Khalil, et al.
Published: (2018-01-01)

Putting insulin resistance into context by dietary reversal of type 2 diabetes
by: R
Published: (2017-06-01)

Intensive Insulin Titration with Insulin Glargine in Insulin-Naive Type 2 Diabetic Patients in Turkey: LANTIT Study
by: Ercan Tuncel, et al.
Published: (2015-09-01)

Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide
by: Minze MG, et al.
Published: (2016-03-01)

Insulin in Type 1 and Type 2 Diabetes—Should the Dose of Insulin Before a Meal be Based on Glycemia or Meal Content?
by: Janusz Krzymien, et al.
Published: (2019-03-01)

Comparison of Insulin Expression Levels in White Blood Cells of infants with and without Family History of Type II Diabetes
by: Reza Mazhari, et al.
Published: (2016-10-01)